OWCP — OWC Pharmaceutical Research Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.46m
Annual cashflow statement for OWC Pharmaceutical Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.07 | -1.65 | -2.29 | -4.56 | -10.3 |
| Depreciation | |||||
| Non-Cash Items | 4.46 | 0.374 | 1.67 | 3.3 | 7.56 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.007 | 0.055 | 0.082 | 0.06 | 0.19 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.602 | -1.22 | -0.529 | -1.19 | -2.5 |
| Capital Expenditures | -0.032 | -0.003 | -0.002 | -0.01 | -0.028 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.032 | -0.003 | -0.002 | -0.01 | -0.028 |
| Financing Cash Flow Items | 0.028 | 0 | — | 0.051 | 0.105 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.09 | 0.124 | 0.646 | 1.69 | 5.02 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.47 | -1.11 | 0.115 | 0.498 | 2.49 |